(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LIRA CLINICAL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

LIRA CLINICAL

ST13

US500000086256085

Class

3

Filing

86256085

Registration

4903588

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

06/05/2026

Trademark type

Combined

Nice classes

3

Filing date

04/18/2014

Registration date

02/23/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/14/2022

Last transaction

06/05/2026

Responsible office

United States Patent and Trademark Office

Status code

701

Official register

Principal Register

First use anywhere

01/13/2010

First use in commerce

01/13/2010

Drawing code

3

Owner type

03

Owner location

Livermore, CA, US

Examiner

KEAN, AMY C

Law office

M30

Current location

TMO LAW OFFICE 112

Mark description

The mark consists of the stylized term "LIRA" above the design of three-pronged molecule to the left of the stylized wording "CLINICAL."

Holders and representatives

Holders

Lira Cosmeceutical, Inc.
Lira Cosmeceutical, Inc.

Representatives

David R Socher DAVID R. SOCHER, ATTORNEY AT LAW

Technical classification

Nice Classes

Class 3

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Body creams; Body wash; Cleansing creams; Cosmetic creams for skin care; Cosmetic preparations for skin care; Facial cleansers; Skin care productsnon-medicated skin serum; Skin lotions; Sun care lotions

Publications

History of USPTO decisions and trademark events.

33 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/14/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/14/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/14/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/14/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/14/2026

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

02/23/2025

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

04/14/2022

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

04/14/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/11/2022

ES8R

TEAS SECTION 8 RECEIVED

10/13/2021

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/23/2021

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

01/30/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/28/2020

ES7R

TEAS SECTION 7 REQUEST RECEIVED

12/16/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

02/23/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/08/2015

PUBO

PUBLISHED FOR OPPOSITION

12/08/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/18/2015

PBPR

WITHDRAWN FROM PUB - ESU SUPERVISOR REQUEST

02/05/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/02/2015

ALIE

ASSIGNED TO LIE

01/27/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/07/2015

XAEC

EXAMINER'S AMENDMENT ENTERED

01/07/2015

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/07/2015

GNEA

EXAMINERS AMENDMENT E-MAILED

01/07/2015

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/07/2015

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/10/2014

GNRT

NON-FINAL ACTION E-MAILED

08/10/2014

CNRT

NON-FINAL ACTION WRITTEN

08/10/2014

DOCK

ASSIGNED TO EXAMINER

07/30/2014

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

05/03/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/02/2014

NWAP

NEW APPLICATION ENTERED

04/22/2014

Continuous trademark protection

Get notified about every new filing that threatens LIRA CLINICAL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.